- Home
- ELSE vs APLM Comparison
ELSE vs APLM Comparison
Compare ELSE & APLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELSE
- APLM
- Stock Information
- Founded
- ELSE 1968
- APLM 2016
- Country
- ELSE United States
- APLM United States
- Employees
- ELSE N/A
- APLM N/A
- Industry
- ELSE Industrial Machinery/Components
- APLM Blank Checks
- Sector
- ELSE Industrials
- APLM Finance
- Exchange
- ELSE Nasdaq
- APLM Nasdaq
- Market Cap
- ELSE 18.1M
- APLM 15.6M
- IPO Year
- ELSE N/A
- APLM N/A
- Fundamental
- Price
- ELSE $5.35
- APLM $10.69
- Analyst Decision
- ELSE
- APLM Strong Buy
- Analyst Count
- ELSE 0
- APLM 2
- Target Price
- ELSE N/A
- APLM $425.00
- AVG Volume (30 Days)
- ELSE 6.1K
- APLM 56.4K
- Earning Date
- ELSE 11-13-2024
- APLM 02-15-2025
- Dividend Yield
- ELSE N/A
- APLM N/A
- EPS Growth
- ELSE 29.91
- APLM N/A
- EPS
- ELSE 0.13
- APLM N/A
- Revenue
- ELSE $9,289,000.00
- APLM $2,101,000.00
- Revenue This Year
- ELSE N/A
- APLM N/A
- Revenue Next Year
- ELSE N/A
- APLM N/A
- P/E Ratio
- ELSE $41.68
- APLM N/A
- Revenue Growth
- ELSE 11.21
- APLM 70.54
- 52 Week Low
- ELSE $3.74
- APLM $6.50
- 52 Week High
- ELSE $5.37
- APLM $105.00
- Technical
- Relative Strength Index (RSI)
- ELSE 69.31
- APLM 53.62
- Support Level
- ELSE $5.14
- APLM $9.19
- Resistance Level
- ELSE $5.31
- APLM $10.45
- Average True Range (ATR)
- ELSE 0.20
- APLM 1.35
- MACD
- ELSE 0.00
- APLM 0.33
- Stochastic Oscillator
- ELSE 97.50
- APLM 72.54
About ELSE Electro-Sensors Inc.
Electro-Sensors Inc is engaged in manufacturing and selling a variety of monitoring systems that measure actual machine production and operation rates, as well as systems that regulate the speed of related machines in production processes. Its speed monitoring systems compare revolutions per minute or speed against acceptable rates as determined by a customer. It also includes a line of products that measure production counts or rates, such as parts, gallons, or board feet, alarm systems, tachometers, and other devices that translate impulses from the sensors into alarm signals, computer inputs, or digital displays that are usable by the customer.
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.